menu search

What counts as a flop when it's an apple movie?

'Killers of the Flower Moon' had a solid opening weekend, but cost $200 million to make. In Hollywood, ...

October 25, 2023, 1:25 am

Macro outlook ‘bad news’ for us equities: blackrock

The global investment manager is bearish on the outlook for US equities as the “inflation rollercoaster” rages on. After a...

October 24, 2023, 9:45 pm

Economic calendar in asia wednesday, 25 october 2023 - australian q3 inflation data

The eagerly awaited Q3 CPI from Australia is due at 11.30am local time:0030 GMT 2030 US Eastern timeHigher than expected CPI will fuel the potential f...

October 24, 2023, 8:03 pm

Google stock slides as cloud business was a ‘big disappointment' in q3

Alphabet Inc (NASDAQ: GOOGL) is down more than 6.0% in extended trading even though it reported solid g...

October 24, 2023, 6:12 pm

S&p 500 gains and losses today: verizon, 3m earnings help power index higher

U.S. equities gained, with the S&P 500 rising 0.7%, amid solid corporate earnings and optimism about th...

October 24, 2023, 5:20 pm

Eqs-news: beaconsmind ag: beaconsmind group announces 1h 2023 financials

Group has prepared consolidated financial statements in accordance with IFRS and reports its key financial figures in Swiss francs. For the first half...

October 24, 2023, 4:30 pm

Etsy analysts cautious into 3q earnings on competitive and macro risks

Etsy (NASDAQ:ETSY) Inc (ETSY) investors should exercise caution before the e-commerce company reports its third-quarter 2023 financial results on No...

October 24, 2023, 3:36 pm

Ge's earnings included an array of nonstandard — and confusing — numbers

But that's no excuse for General Electric Co.'s GE, +7.37% third-quarter earnings release early Tuesday to include quite so many nonstandard, non-GAAP...

October 24, 2023, 3:34 pm

Is 6%-yielding oneok an unbeatable s&p 500 income play?

ONEOK, Inc. is making the case that it's the best high-yield stock in the S&P 500 based on several criteria. The company has a...

October 24, 2023, 3:00 pm

Payhawk partners with wise platform to streamline global payments

Global spend management solution Payhawk has partnered with global payment infrastructure firm Wise Platform to provide faster and more cost-effec...

October 24, 2023, 2:56 pm

3 reasons growth investors will love servicenow (now)

ServiceNow (NOW) possesses solid growth attributes, which could help it handily outperform the market....

October 24, 2023, 2:17 pm

Is o'reilly automotive (orly) a solid growth stock? 3 reasons to think "yes"

O'Reilly Automotive (ORLY) could produce exceptional returns because of its solid growth attributes....

October 24, 2023, 2:17 pm

Gaming etfs to buy on solid cash reserves & merger potential?

A new report from venture capital firm Konvoy, as quoted on CNBC, reveals that publicly listed gaming companies are holding a substantial $45 billion ...

October 24, 2023, 2:17 pm

Gbp/jpy forecast – the british pound gives up early gains against the yen

The British pound initially rallied during the trading session on Tuesday but gave up gains rather quickly as we continue to see a lot of volatility. ...

October 24, 2023, 1:56 pm

Paccar's (pcar) trucks & parts units exceed expectations in q3

PACCAR (PCAR) not only delivers a comprehensive beat in Q3 but also witnesses year-over-year growth of 59.2% and 23.2%, respectively, in its earnings ...

October 24, 2023, 1:32 pm

Usd/jpy mid-day outlook

Daily Pivots: (S1) 149.52; (P) 149.75; (R1) 149.95; More… Intraday bias in USD/JPY remains neutral at this point. Consolidation pattern from 150.15 ...

October 24, 2023, 1:17 pm

Rli q3 earnings top, revenues lag estimates, premiums up y/y

RLI Q3 results reflect higher gross premiums written and solid underwriting performance despite losses ...

October 24, 2023, 12:47 pm

W.r. berkley (wrb) q3 earnings top on solid underwriting

W.R. Berkley (WRB) Q3 reflects higher premiums, driven by strong rate increases in nearly all lines of business, exposure growth that fueled continued...

October 24, 2023, 12:47 pm

Lisata therapeutics announces first patient treated in the cholangiocarcinoma cohort of the bolster trial of lsta1, a novel tumor-targeting and penetrating peptide

Phase 2a double-blind, placebo-controlled, multi-center, randomized study evaluating LSTA1 in combination with standard-of-care versus standard-of-car...

October 24, 2023, 12:00 pm

Will segmental sales aid textron's (txt) earnings in q3?

Textron's (TXT) Q3 results are likely to reflect a solid revenue performance across the majority of its...

October 24, 2023, 10:33 am


Search within

Pages Search Results: